SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-240991
Filing Date
2022-09-08
Accepted
2022-09-08 16:03:04
Documents
14
Period of Report
2022-09-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d403635d8k.htm   iXBRL 8-K 33610
2 EX-10.1 d403635dex101.htm EX-10.1 52395
3 EX-10.2 d403635dex102.htm EX-10.2 7784
  Complete submission text file 0001193125-22-240991.txt   237424

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA fixx-20220906.xsd EX-101.SCH 2887
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE fixx-20220906_lab.xml EX-101.LAB 17979
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fixx-20220906_pre.xml EX-101.PRE 11279
8 EXTRACTED XBRL INSTANCE DOCUMENT d403635d8k_htm.xml XML 3344
Mailing Address ONE PATRIOTS PARK BEDFORD MA 01730
Business Address ONE PATRIOTS PARK BEDFORD MA 01730 781-301-7277
Homology Medicines, Inc. (Filer) CIK: 0001661998 (see all company filings)

IRS No.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38433 | Film No.: 221233857
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences